# Naproxen Sodium and Diphenhydramine HCl

NDC: 69238-1422
Generic name: Naproxen Sodium and Diphenhydramine
Labeler / Manufacturer: Amneal Pharmaceuticals NY LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20181023

FDA application: ANDA209726

## Active ingredients

- DIPHENHYDRAMINE HYDROCHLORIDE: 25 mg/1
- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69238-1422"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69238-1422
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=caca14cf-95f2-4c60-8bba-2154b8f353a3